Westat — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Westat appears in 22 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials22

Recruiting shown4

Roles2

SourceClinicalTrials.gov

Clinical trials

22 shown

Screen2Prevent (S2P)NCT07728123 · lead sponsor · 2026-06-16

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young AdultsNCT06444360 · lead sponsor · 2025-11-04

Linking Youth to Pre-Exposure Prophylaxis (PrEP) ServicesNCT07438041 · lead sponsor · 2026-07-27

NOT_YET_RECRUITING

Combatting HIV Or Other STIs Early (CHOOSE)NCT07510048 · lead sponsor · 2026-07-20

NOT_YET_RECRUITING

Prospective Cohort Study of HIV and Zika in Infants and PregnancyNCT03263195 · lead sponsor · 2017-08-23

Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant WomenNCT02717494 · lead sponsor · 2016-03-01

Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child TransmissionNCT01618305 · lead sponsor · 2013-09-05

WEAVE NM: Heart Health and Nutrition for LifeNCT07074145 · collaborator · 2025-02-21

Trial of a Harm Reduction Strategy for People With HIV Who Smoke CigarettesNCT05642715 · collaborator · 2024-04-04

Healthy Living Anson StudyNCT07126587 · collaborator · 2025-09-24

Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.NCT06926855 · collaborator · 2025-05-01

Community Engagement Alliance Against DisparitiesNCT06607341 · collaborator · 2024-12-20

ACTIVE_NOT_RECRUITING

VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung CancerNCT05374538 · collaborator · 2022-11-09

Maternal Health Diabetes Prevention StudyNCT05343494 · collaborator · 2022-04-04

Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular InjectionNCT03913195 · collaborator · 2019-05-30

RCT of an Internet Cessation Program Plus Online Social Network for HIV+ SmokersNCT02781090 · collaborator · 2016-07-06

Implementation of National Guidelines for Treatment of PsychosesNCT03271242 · collaborator · 2016-06-22

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1NCT02707861 · collaborator · 2016-03-01

Demonstration Project of PrEP Among Female Sex Workers in Dakar, SenegalNCT02474303 · collaborator · 2015-07-01

Philadelphia Telemedicine Glaucoma Detection and Follow-Up StudyNCT02390245 · collaborator · 2014-09-01

Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ YouthNCT01969461 · collaborator · 2014-07-01

Feeding My Baby - A National WIC StudyNCT02031978 · collaborator · 2013-07-01

Drugs studied in this sponsor's trials

9 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Westat as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

efavirenz1

ibalizumab1

ibalizumab-uiyk1

lamivudine / zidovudine1

nicotine polacrilex1

raltegravir1

sotorasib1

Truvada1

efavirenz RxCUI 195085 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ibalizumab RxCUI 2043283 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ibalizumab-uiyk RxCUI 2043313 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lamivudine / zidovudine RxCUI 214671 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial nicotine polacrilex RxCUI 31765 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial raltegravir RxCUI 719872 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial sotorasib RxCUI 2550714 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Truvada RxCUI 495430 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial varenicline RxCUI 591622 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

collaborator15

lead sponsor7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.